Westpac Banking Corp Grows Stake in Henry Schein, Inc. (NASDAQ:HSIC)
Westpac Banking Corp increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 105,054 shares of the company’s stock after buying an additional 700 shares during the quarter. Westpac Banking Corp owned about 0.07% of Henry Schein worth $6,175,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Lountzis Asset Management LLC purchased a new position in Henry Schein during the 2nd quarter worth approximately $35,000. Flagship Harbor Advisors LLC lifted its position in Henry Schein by 33.3% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 800 shares of the company’s stock worth $46,000 after acquiring an additional 200 shares during the period. Fifth Third Bancorp lifted its position in Henry Schein by 23.5% during the 3rd quarter. Fifth Third Bancorp now owns 784 shares of the company’s stock worth $46,000 after acquiring an additional 149 shares during the period. Canton Hathaway LLC acquired a new stake in Henry Schein during the 3rd quarter worth approximately $49,000. Finally, Cerebellum GP LLC acquired a new stake in Henry Schein during the 3rd quarter worth approximately $63,000. Hedge funds and other institutional investors own 99.97% of the company’s stock.
HSIC has been the subject of a number of recent research reports. BidaskClub cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, November 5th. TheStreet raised Henry Schein from a “c” rating to a “b” rating in a research report on Monday, November 2nd. ValuEngine cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Friday, August 7th. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $63.00 price objective for the company in a research report on Wednesday, November 4th. Finally, Barrington Research raised Henry Schein from a “market perform” rating to an “outperform” rating and set a $72.00 price target for the company in a report on Tuesday, November 3rd. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $61.91.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, November 2nd. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.26. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.45 billion. Henry Schein had a net margin of 6.14% and a return on equity of 11.60%. Henry Schein’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.90 EPS. As a group, analysts expect that Henry Schein, Inc. will post 2.9 EPS for the current year.
About Henry Schein
Henry Schein, Inc, a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: How to calculate compound interest
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.